360 related articles for article (PubMed ID: 31780564)
1. Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomes.
Bogani G; Tibiletti MG; Ricci MT; Carnevali I; Liberale V; Paolini B; Milione M; Vitellaro M; Murgia F; Chiappa V; Ditto A; Ghezzi F; Raspagliesi F
Int J Gynecol Cancer; 2020 Jan; 30(1):56-61. PubMed ID: 31780564
[TBL] [Abstract][Full Text] [Related]
2. Impact of gene-specific germline pathogenic variants on presentation of endometrial cancer in Lynch syndrome.
Bogani G; Ricci MT; Vitellaro M; Ditto A; Chiappa V; Raspagliesi F
Int J Gynecol Cancer; 2019 May; 29(4):705-710. PubMed ID: 30772826
[TBL] [Abstract][Full Text] [Related]
3. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic Characteristics of Endometrial Cancer in Lynch Syndrome: A French Multicenter Study.
Rossi L; Le Frere-Belda MA; Laurent-Puig P; Buecher B; De Pauw A; Stoppa-Lyonnet D; Canlorbe G; Caron O; Borghese B; Colas C; Delhomelle H; Chabbert-Buffet N; Grandjouan S; Lecuru F; Bats AS
Int J Gynecol Cancer; 2017 Jun; 27(5):953-960. PubMed ID: 28525912
[TBL] [Abstract][Full Text] [Related]
5. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
6. Targeted Next-Generation Sequencing of
Özdemir TR; Alan M; Sancı M; Koç A
Balkan Med J; 2019 Jan; 36(1):37-42. PubMed ID: 30238922
[TBL] [Abstract][Full Text] [Related]
7. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK
Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123
[TBL] [Abstract][Full Text] [Related]
8. Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types.
Carcangiu ML; Radice P; Casalini P; Bertario L; Merola M; Sala P
Int J Surg Pathol; 2010 Feb; 18(1):21-6. PubMed ID: 19443869
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
[TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
11. [Lynch syndrome-related endometrial carcinoma].
Pang SJ; Guo DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):494-7. PubMed ID: 22932468
[No Abstract] [Full Text] [Related]
12. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
[TBL] [Abstract][Full Text] [Related]
13. Variable Expression of MSH6 in Endometrial Carcinomas With Intact Mismatch Repair and With MLH1 Loss Due to MLH1 Methylation.
Tandon N; Hudgens C; Fellman B; Tetzlaff MT; Broaddus RR
Int J Gynecol Pathol; 2020 Nov; 39(6):507-513. PubMed ID: 31855955
[TBL] [Abstract][Full Text] [Related]
14. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.
Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M
Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366
[TBL] [Abstract][Full Text] [Related]
15. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
[TBL] [Abstract][Full Text] [Related]
16. Coexistent Dedifferentiated Endometrioid Carcinoma of the Uterus and Adenocarcinoma of the Bladder in Lynch Syndrome: Case Report and Review of the Literature.
Groth JV; Prabhu S; Periakaruppan R; Ohlander S; Emmadi R; Kothari R
Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):e26-e30. PubMed ID: 32167968
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens.
Chapel DB; Yamada SD; Cowan M; Lastra RR
Gynecol Oncol; 2018 Jun; 149(3):570-574. PubMed ID: 29656794
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors.
Ketabi Z; Bartuma K; Bernstein I; Malander S; Grönberg H; Björck E; Holck S; Nilbert M
Gynecol Oncol; 2011 Jun; 121(3):462-5. PubMed ID: 21388660
[TBL] [Abstract][Full Text] [Related]
19. Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
Adar T; Rodgers LH; Shannon KM; Yoshida M; Ma T; Mattia A; Lauwers GY; Iafrate AJ; Hartford NM; Oliva E; Chung DC
Cancer; 2018 Aug; 124(15):3145-3153. PubMed ID: 29750335
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas.
Shikama A; Minaguchi T; Matsumoto K; Akiyama-Abe A; Nakamura Y; Michikami H; Nakao S; Sakurai M; Ochi H; Onuki M; Satoh T; Oki A; Yoshikawa H
Gynecol Oncol; 2016 Feb; 140(2):226-33. PubMed ID: 26644264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
